Sharon Finch started Medius fourteen years ago and has almost 30 years international experience in business development in multinational, small pharma and Japanese companies.
Roger Davies previously Director of Business Development at Bioglan and Mundipharma, Roger specialises in clinical stage deals and product/corporate acquisitions and deal valuations.
Chris Piggott has a successful track record of business development both in the US and in Europe. He was previously a VP with Sanofi-Aventis before joining Medius.
Sheila Chalmers directs our in depth market intelligence services as well as researching and writing analytical and medical reports.
Linda Sterrett is our Office Director and also is responsible for the management of our Training programmes. Linda has worked with Medius for over 10 years and provides logistical support for our executive team.
John Ansell focuses on international projects that are commercial and strategic, reflecting his previous industry marketing and business development experience.
Alan Warrander has recently started working with Medius and has over 25 years in depth industry experience having worked with AstraZeneca and as a Consultant with WoodMackenzie.
Christi Mitchellprovides expertise in the acquisition of intellectual Property Rights and in the licensing out of technologies.
Based in San Francisco, Stuart Wren advises on corporate development strategy and on alliances. Stuart also has extensive experience in Japan where he was Director of Business Development for GSK.
Jill Ogden has over 21 years’ experience in the biopharmaceuticals and healthcare industries. Jill provides our drug delivery expertise where she combines commercial experience with a strong scientific background.
Elizabeth McNabb has international experience working with international corporations, NGOs and governments in the fields of nutraceuticals, devices and environmental technologies.
